Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Tumour necrosis in chromophobe renal cell carcinoma: clinical data to distinguish aggressive variants.

Zini L, Leroy X, Lemaitre L, Devos P, Aubert S, Biserte J, Villers A.

Eur J Surg Oncol. 2008 Jun;34(6):687-91.

PMID:
17997271
2.

Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.

Volpe A, Novara G, Antonelli A, Bertini R, Billia M, Carmignani G, Cunico SC, Longo N, Martignoni G, Minervini A, Mirone V, Simonato A, Terrone C, Zattoni F, Ficarra V; Surveillance and Treatment Update on Renal Neoplasms (SATURN) Project.; Leading Urological No-Profit Foundation for Advanced Research (LUNA) Foundation..

BJU Int. 2012 Jul;110(1):76-83. doi: 10.1111/j.1464-410X.2011.10690.x.

3.

Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases.

Amin MB, Paner GP, Alvarado-Cabrero I, Young AN, Stricker HJ, Lyles RH, Moch H.

Am J Surg Pathol. 2008 Dec;32(12):1822-34. doi: 10.1097/PAS.0b013e3181831e68.

PMID:
18813125
4.

The correlation between size of renal cell carcinoma and its histopathological characteristics: a single center study of 1867 renal cell carcinoma cases.

Zhang C, Li X, Hao H, Yu W, He Z, Zhou L.

BJU Int. 2012 Dec;110(11 Pt B):E481-5. doi: 10.1111/j.1464-410X.2012.11173.x.

5.

Cyst-associated renal cell carcinoma: clinicopathologic characteristics and evaluation of prognosis in 27 cases.

Onishi T, Oishi Y, Goto H, Tomita M, Abe K, Sugaya S.

Int J Urol. 2001 Jun;8(6):268-74.

6.

External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.

Zigeuner R, Hutterer G, Chromecki T, Imamovic A, Kampel-Kettner K, Rehak P, Langner C, Pummer K.

Eur Urol. 2010 Jan;57(1):102-9. doi: 10.1016/j.eururo.2008.11.033.

PMID:
19062157
7.

Contrast-enhanced CT in 100 clear cell renal cell cancers - an analysis of enhancement, tumour size, and survival.

Veeratterapillay R, Ijabla R, Conaway D, Haslam P, Soomro N, Heer R.

Clin Radiol. 2015 Dec;70(12):1357-61. doi: 10.1016/j.crad.2015.07.006.

PMID:
26337011
8.

Unclassified renal cell carcinoma: a report of 56 cases.

Lopez-Beltran A, Kirkali Z, Montironi R, Blanca A, Algaba F, Scarpelli M, Yorukoglu K, Hartmann A, Cheng L.

BJU Int. 2012 Sep;110(6):786-93. doi: 10.1111/j.1464-410X.2012.10934.x.

9.

[Relevance of the clinical-pathological predictive factors in force in chromophobe renal cell cancer].

Pardo P, Rodríguez-Faba O, Palou J, Algaba F, Breda A, Esquena S, Villavicencio H.

Actas Urol Esp. 2012 Oct;36(9):527-31. Spanish.

PMID:
22365081
10.

A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade.

Paner GP, Amin MB, Alvarado-Cabrero I, Young AN, Stricker HJ, Moch H, Lyles RH.

Am J Surg Pathol. 2010 Sep;34(9):1233-40. doi: 10.1097/PAS.0b013e3181e96f2a.

PMID:
20679882
11.

Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness.

Sengupta S, Lohse CM, Leibovich BC, Frank I, Thompson RH, Webster WS, Zincke H, Blute ML, Cheville JC, Kwon ED.

Cancer. 2005 Aug 1;104(3):511-20.

12.

Collecting duct renal cell carcinoma: a matched analysis of 41 cases.

Karakiewicz PI, Trinh QD, Rioux-Leclercq N, de la Taille A, Novara G, Tostain J, Cindolo L, Ficarra V, Artibani W, Schips L, Zigeuner R, Mulders PF, Lechevallier E, Coulange C, Valeri A, Descotes JL, Rambeaud JJ, Abbou CC, Lang H, Jacqmin D, Mejean A, Patard JJ.

Eur Urol. 2007 Oct;52(4):1140-5.

PMID:
17336449
13.

Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.

Amin MB, Corless CL, Renshaw AA, Tickoo SK, Kubus J, Schultz DS.

Am J Surg Pathol. 1997 Jun;21(6):621-35.

PMID:
9199639
14.

Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus.

Kim KH, You D, Jeong IG, Kwon TW, Cho YM, Hong JH, Ahn H, Kim CS.

BJU Int. 2012 Dec;110(11 Pt B):E673-8. doi: 10.1111/j.1464-410X.2012.11498.x.

15.

Chromophobe renal cell carcinoma: analysis of 61 cases.

Peyromaure M, Misrai V, Thiounn N, Vieillefond A, Zerbib M, Flam TA, Debré B.

Cancer. 2004 Apr 1;100(7):1406-10.

16.

Chromophobe renal cell carcinoma: comprehensive analysis of 104 cases from multicenter European database.

Cindolo L, de la Taille A, Schips L, Zigeuner RE, Ficarra V, Tostain J, Artibani W, Gallo A, Salzano L, Patard JJ.

Urology. 2005 Apr;65(4):681-6.

PMID:
15833508
17.

Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma.

Shuch B, Bratslavsky G, Shih J, Vourganti S, Finley D, Castor B, Treat E, Linehan WM, Pantuck AJ, Said JW, Belldegrun AS.

BJU Int. 2012 Jun;109(11):1600-6. doi: 10.1111/j.1464-410X.2011.10785.x.

18.

Cystic renal cell carcinoma: biology and clinical behavior.

Han KR, Janzen NK, McWhorter VC, Kim HL, Pantuck AJ, Zisman A, Figlin RA, Dorey FJ, Said JW, Belldegrun AS.

Urol Oncol. 2004 Sep-Oct;22(5):410-4.

PMID:
15464922
19.

Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma.

Serrano MF, Katz M, Yan Y, Kibel AS, Humphrey PA.

Cancer. 2008 Aug 1;113(3):477-83. doi: 10.1002/cncr.23574.

20.

Significance of TNM staging, Demographic and Histologic Features in Predicting the Prognosis of Renal Cell Carcinoma.

Kucuk U, Pala EE, Sezer O, Cakir E, Bayol U, Divrik RT.

Acta Chir Belg. 2015 May-Jun;115(3):202-7.

PMID:
26158251
Items per page

Supplemental Content

Support Center